These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12358270)

  • 1. Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices.
    Arguedas MR; Heudebert GR; Eloubeidi MA; Abrams GA; Fallon MB
    Am J Gastroenterol; 2002 Sep; 97(9):2441-52. PubMed ID: 12358270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model.
    Saab S; DeRosa V; Nieto J; Durazo F; Han S; Roth B
    Am J Gastroenterol; 2003 Apr; 98(4):763-70. PubMed ID: 12738453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective?
    Spiegel BM; Targownik L; Dulai GS; Karsan HA; Gralnek IM
    Hepatology; 2003 Feb; 37(2):366-77. PubMed ID: 12540787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis.
    Imperiale TF; Chalasani N; Klein RW
    Am J Gastroenterol; 2003 Dec; 98(12):2742-50. PubMed ID: 14687827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PillCam ESO versus esophagogastroduodenoscopy in esophageal variceal screening: A decision analysis.
    White CM; Kilgore ML
    J Clin Gastroenterol; 2009; 43(10):975-81. PubMed ID: 19661814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The budget impact of endoscopic screening for esophageal varices in cirrhosis.
    Spiegel BM; Esrailian E; Eisen G
    Gastrointest Endosc; 2007 Oct; 66(4):679-92. PubMed ID: 17905009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
    Lin OS; Keeffe EB; Sanders GD; Owens DK
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of screening and preventive therapies for gastroesophageal varices in patients referred for evaluation of orthotopic liver transplantation.
    Arguedas MR; McGuire BM; Fallon MB; Abrams GA
    Am J Gastroenterol; 2001 Mar; 96(3):833-7. PubMed ID: 11280560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding.
    Imperiale TF; Klein RW; Chalasani N
    Hepatology; 2007 Apr; 45(4):870-8. PubMed ID: 17393528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates.
    Roberts DN; Arguedas MR; Fallon MB
    Liver Transpl; 2007 Feb; 13(2):206-14. PubMed ID: 17205561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage.
    Targownik LE; Spiegel BM; Dulai GS; Karsan HA; Gralnek IM
    Am J Gastroenterol; 2004 Jul; 99(7):1306-15. PubMed ID: 15233670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
    Kwon JS; Lu KH
    Obstet Gynecol; 2008 Jul; 112(1):56-63. PubMed ID: 18591308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices.
    Di Pascoli L; Buja A; Bolognesi M; Montagnese S; Gatta A; Gregori D; Merkel C
    World J Gastroenterol; 2014 Aug; 20(30):10464-9. PubMed ID: 25132763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic screening for gastric cancer.
    Dan YY; So JB; Yeoh KG
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing first variceal hemorrhage in cirrhosis.
    Albillos A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S305-11. PubMed ID: 17975481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors.
    Day FL; Karnon J; Rischin D
    J Clin Oncol; 2011 Aug; 29(24):3270-7. PubMed ID: 21788556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.
    Das A
    Am J Gastroenterol; 1998 Oct; 93(10):1895-900. PubMed ID: 9772051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?
    Anderson R; Haas M; Shanahan M
    Aust N Z J Public Health; 2008 Feb; 32(1):43-52. PubMed ID: 18290913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.